Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

JM Barnett; A Cadman; D Gor; M Dempsey; M Walters; A Candlin; M Tisdale; PJ Morley; IJ Owens; RJ Fenton; AP Lewis; ECJ Claas; Guus Rimmelzwaan; Ronald Groot; Ab Osterhaus

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

JM Barnett, A Cadman, D Gor, M Dempsey, M Walters, A Candlin, M Tisdale, PJ Morley, IJ Owens, RJ Fenton, AP Lewis, ECJ Claas, Guus Rimmelzwaan, Ronald Groot, Ab Osterhaus

Research output: Contribution to journal › Article › Academic › peer-review

103 Citations (Scopus)

13 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	78-87
Number of pages	10
Journal	Antimicrobial Agents & Chemotherapy
Volume	44
Issue number	1
Publication status	Published - 2000

Research programs

EMC MM-04-27-01
EMC MM-04-54-08-A

Access to Document

10602727.pdfFinal published version, 109 KB

http://hdl.handle.net/1765/9217

Cite this

Barnett, JM., Cadman, A., Gor, D., Dempsey, M., Walters, M., Candlin, A., Tisdale, M., Morley, PJ., Owens, IJ., Fenton, RJ., Lewis, AP., Claas, ECJ., Rimmelzwaan, G., Groot, R., & Osterhaus, A. (2000). Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrobial Agents & Chemotherapy, 44(1), 78-87. http://hdl.handle.net/1765/9217

@article{fb851e5b36b84127939a4e1020c9bd0f,

title = "Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies",

author = "JM Barnett and A Cadman and D Gor and M Dempsey and M Walters and A Candlin and M Tisdale and PJ Morley and IJ Owens and RJ Fenton and AP Lewis and ECJ Claas and Guus Rimmelzwaan and Ronald Groot and Ab Osterhaus",

year = "2000",

language = "Undefined/Unknown",

volume = "44",

pages = "78--87",

journal = "Antimicrobial Agents & Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "1",

}

Barnett, JM, Cadman, A, Gor, D, Dempsey, M, Walters, M, Candlin, A, Tisdale, M, Morley, PJ, Owens, IJ, Fenton, RJ, Lewis, AP, Claas, ECJ, Rimmelzwaan, G, Groot, R & Osterhaus, A 2000, 'Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies', Antimicrobial Agents & Chemotherapy, vol. 44, no. 1, pp. 78-87. <http://hdl.handle.net/1765/9217>

TY - JOUR

T1 - Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

AU - Barnett, JM

AU - Cadman, A

AU - Gor, D

AU - Dempsey, M

AU - Walters, M

AU - Candlin, A

AU - Tisdale, M

AU - Morley, PJ

AU - Owens, IJ

AU - Fenton, RJ

AU - Lewis, AP

AU - Claas, ECJ

AU - Rimmelzwaan, Guus

AU - Groot, Ronald

AU - Osterhaus, Ab

PY - 2000

Y1 - 2000

M3 - Article

SN - 0066-4804

VL - 44

SP - 78

EP - 87

JO - Antimicrobial Agents & Chemotherapy

JF - Antimicrobial Agents & Chemotherapy

IS - 1

ER -